IXICO PLC
LSE:IXI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
IXICO PLC
LSE:IXI
|
UK |
|
Fukuoka Financial Group Inc
OTC:FKKFY
|
JP |
|
M
|
Mastern Premier Reit 1
KRX:357430
|
KR |
|
P
|
PAL Group Holdings Co Ltd
TSE:2726
|
JP |
|
PropNex Ltd
SGX:OYY
|
SG |
|
Shanta Gold Ltd
LSE:SHG
|
GG |
|
Lider Faktoring AS
IST:LIDFA.E
|
TR |
|
Rechi Precision Co Ltd
TWSE:4532
|
TW |
IXICO PLC
IXICO Plc engages in the provision of technology-enabled specialty services to the global biopharmaceutical industry. The Company’s data analytics services are used by the global biopharmaceutical industry to interpret data from brain scans and digital biosensors to enable trial design, site qualification, patient selection and clinical outcomes. The company provides technology-enabled services across all phases of clinical evaluation. The Company’s services include the collection, analysis, management and reporting of data generated during a clinical study and the outputs from the data analysis. The Company’s integrated digital platform provides a scalable and secure infrastructure for the capture and analysis of regulatory compliant clinical data to enable clients to make better-informed decisions. Its geographical area includes Switzerland, United Kingdom, United States of America, Netherlands, Ireland and Europe.
IXICO Plc engages in the provision of technology-enabled specialty services to the global biopharmaceutical industry. The Company’s data analytics services are used by the global biopharmaceutical industry to interpret data from brain scans and digital biosensors to enable trial design, site qualification, patient selection and clinical outcomes. The company provides technology-enabled services across all phases of clinical evaluation. The Company’s services include the collection, analysis, management and reporting of data generated during a clinical study and the outputs from the data analysis. The Company’s integrated digital platform provides a scalable and secure infrastructure for the capture and analysis of regulatory compliant clinical data to enable clients to make better-informed decisions. Its geographical area includes Switzerland, United Kingdom, United States of America, Netherlands, Ireland and Europe.
